| Title: | Protein Drug Targets for Abdominal Aortic Aneurysm and Proteomic Associations Between Modifiable Risk Factors and Abdominal Aortic Aneurysm |
| Journal: | Journal of the American Heart Association |
| Published: | 26 Feb 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/40008516/ |
| DOI: | https://doi.org/10.1161/jaha.124.037802 |
Publication 15923
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BACKGROUND: Abdominal aortic aneurysm (AAA) is a severe aortic disease for which no pharmacological interventions have yet been developed. This investigation focused on identifying protein-based therapeutic targets and assessing how proteins mediate the interplay between modifiable risk factors and AAA development.</p>
METHODS: Causal inferences between plasma proteins and AAA were drawn using 2-sample Mendelian randomization, followed by comprehensive sensitivity testing, colocalization, and replication efforts. Further analyses included database interrogation, single-cell RNA data analysis, enrichment analysis, protein-protein interaction networks, and immunohistochemistry to map the tissue-specific expression of these proteins, their expression within AAA tissues, and their biological roles. Mediation Mendelian randomization was employed to evaluate the mediating effects of AAA-related proteins on the associations between AAA and 3 risk factors: hypertension, smoking, and obesity.</p>
RESULTS: A total of 43 proteins were identified as having causal links to AAA. Colocalization analysis pinpointed 13 proteins with strong evidence of colocalization with AAA. Of these, the causal involvement of 10 proteins was substantiated by external validation data. Consistent evidence for PCSK9 (proprotein convertase subtilisin/kexin type 9), IL6R (interleukin-6R), ECM1 (extracellular matrix protein 1), and ANGPTL4 (angiopoietin-related protein 4) was further validated through tissue immunohistochemistry and blood data. Moreover, Mendelian randomization analysis identified 10 proteins as mediators of the influence of hypertension, smoking, and obesity on AAA development.</p>
CONCLUSIONS: This analysis identifies 4 proteins (PCSK9, IL6R, ECM1, and ANGPTL4) as high-priority therapeutic targets for AAA and emphasizes the intermediary role of plasma proteins in linking hypertension, smoking, obesity, and AAA. Further investigations are needed to clarify the specific roles of these proteins in AAA pathology.</p>
11 Keywords
- Aortic Aneurysm, Abdominal
- Blood Proteins
- Humans
- Hypertension
- Male
- Mendelian Randomization Analysis
- Obesity
- Protein Interaction Maps
- Proteomics
- Risk Factors
- Smoking
9 Authors
- Yao Qi
- Han Jiang
- Yu Lun
- Qingwei Gang
- Shikai Shen
- Han Zhang
- Mingyu Liu
- Yixian Wang
- Jian Zhang
Enabling scientific discoveries that improve human health